BioSpace News Archive

bArtivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the fourth quarter and full year ended December 31, 2021.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced updates on its investigational gene therapy programs in clinical development.

Arena Pharmaceuticals, Inc. announced that the Compensation Committee of its Board of Directors granted to 18 new employees 18,527 inducement restricted stock units.

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the granting of patent number 6998478 titled “Powered Orthotic Device and Method of Using Same” by the Japanese Patent Office.

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced its vendor neutral image viewer Philips Enterprise Viewer – Vue Motion – has won KLAS Research’s ‘2022 Best in KLAS Universal Viewer ’ award.

Movano Inc. (NASDAQ:MOVE), today announced the completion of an Institutional Review Board (IRB)-approved glucose pilot study, which was conducted on 10 participants with type 1 diabetes of varying gender, age, ethnicity and weight in conjunction with an independent FDA-compliant clinical lab.

Harpak-ULMA announced the expansion of its North American initiative to help medical device manufacturers improve their flexibility and operational packaging performance in response to skilled labor disruptions and related potential quality concerns.

Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced commencement of production of its first dendritic cell cancer vaccine for a compassionate use patient at its recently licensed production facility in Sawston, UK.

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today provided a business update for the fourth quarter of 2021, including certain estimated unaudited preliminary financial data.

Paige, the global leader in AI-based diagnostic software in pathology, and Flagship Biosciences, a leader in data-centric pathology and tissue analysis, today announced a partnership to provide access to Flagship’s TissueInsight™, an AI-aided diagnostics software that quantifies PD-L1 expression in immunohistochemistry tissue samples, directly through the Paige Platform.